![]() |
市場調查報告書
商品編碼
1496879
全球椎體成形術和椎體後凸成形術市場 - 2024-2031Global Vertebroplasty and Kyphoplasty Market - 2024-2031 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
司機
骨質疏鬆症和脊椎疾病的發生率上升
全球椎體成形術和椎體後凸成形術市場的需求是由多種因素所驅動的。骨質疏鬆症是美國普遍存在的公共衛生問題。美國衛生局局長最近向美國人介紹了骨質疏鬆症的重要性,廣泛的研究表明,椎體壓迫性骨折是骨質疏鬆症最常見的併發症之一。
白人女性終生罹患骨質疏鬆性脊椎骨折的風險為 15.6%。美國每年診斷出超過 70 萬起繼發於骨質疏鬆症的椎體骨折,導致 11.5 萬人入院治療。骨質疏鬆性壓迫性骨折的主要後果是背痛、脊椎後凸和身高下降。
此外,該行業的主要參與者推出新產品和技術將推動該市場的成長。例如,2023 年 10 月,荷蘭公司 Amber Implants 開始開發用於脊椎損傷的下一代植入物,開始對其 VCFix 脊椎系統進行臨床試驗。該植入物旨在透過椎弓根錨定來最佳化脊椎中的負荷分佈。
首次人體試驗將評估 VCFix 對椎骨壓迫性骨折患者的安全性和有效性。它還包含一次性無菌手術套件,以確保可追溯性並降低感染風險。
此外,2021年8月,IZI Medical正式推出Vertefix HV Cement,該產品旨在解決椎體成形術和椎體後凸成形術中水泥注射過程中即時流量可視化的需求。
限制
與治療相關的高成本、嚴格的監管框架、與手術相關的併發症、缺乏熟練的專業人員以及有限的報銷政策等因素預計將阻礙市場。
有關此報告的更多詳細資訊 - 索取樣本
Overview
The global vertebroplasty and kyphoplasty market reached US$ 1.2 billion in 2023 and is expected to reach US$ 1.7 billion by 2031, growing at a CAGR of 5% during the forecast period 2024-2031.
Vertebroplasty and kyphoplasty are relatively new techniques for the treatment of pain caused by vertebral body compression fractures and stabilize the spine, thereby preventing further spinal dysfunction and improving quality of life.
Kyphoplasty differs from vertebroplasty in that a balloon is first inflated in the vertebral body to create a cavity into which cement is then injected under lower pressure. Kyphosis is a modern spine surgery procedure used to stabilize vertebral compression fractures caused by osteoporosis, cancer, and other conditions.
The market is driven by factors such as a rise in the adoption of minimally invasive surgeries, a rising incidence of osteoporosis & spinal disorders, an increase in the geriatric population, a rise in accidental cases, and technological advancements in healthcare.
Market Dynamics
Drivers
Rising Incidence of Osteoporosis & Spinal Disorders
The demand for the global vertebroplasty and kyphoplasty market is driven by multiple factors. Osteoporosis is a widespread public health problem in the United States. The surgeon general of the United States has recently introduced special attention to the importance of osteoporosis to Americans extensive study states that vertebral body compression fractures are among the most common complications of osteoporosis.
The lifetime risk of osteoporotic spine fracture in white women is 15.6%. Each year, more than 700,000 vertebral body fractures secondary to osteoporosis are diagnosed in the United States, resulting in 115,000 hospital admissions. The major consequences of osteoporotic compression fractures are back pain, kyphosis, and height loss.
Moreover, major key players in the industry launching new products and technology would propel this market growth. For instance, in October 2023, Amber Implants, a Netherlands-based company developing next-gen implants for spinal injuries, began clinical trials for its VCFix spinal system. The implant seeks to optimize load distribution in the spine via pedicle anchorage.
The first-in-human trial will evaluate VCFix's safety and efficacy for patients with vertebral compression fractures. It's also included with a single-use, sterile surgical kit to ensure traceability and reduce infection risk.
Also, in August 2021, IZI Medical officially launched Vertefix HV Cement, a product which aims to address the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures.
Restraints
Factors such as the high cost associated with the treatment, stringent regulatory framework, complications associated with the procedures, lack of skilled professionals, and limited reimbursement policies are expected to hamper the market.
For more details on this report - Request for Sample
The global vertebroplasty and kyphoplasty market is segmented based on device type, application, end-user, and region.
The kyphoplasty device segment accounted for approximately 62.5% of the global vertebroplasty and kyphoplasty market share
The kyphoplasty segment is expected to hold the largest market share over the forecast period owing to the advantages that kyphoplasty provides over vertebroplasty, such as reduction in back pain, as well as restoration of vertebral body height, and a lower rate of cement extravasation. This is mainly done by placing balloons to gently elevate the fractured vertebrae in an attempt to return them to the correct position.
According to the study published in Frontiers in Surgery Journal in July 2022, the use of kyphoplasty for the clinical treatment of osteoporotic vertebral compression fractures, spinal metastatic tumors, hemangiomas, myelomas, and vertebral nonunion has increased with the global development of minimally invasive spinal surgery.
Therefore, the rising adoption of kyphoplasty procedures for the treatment of vertebral compression fractures and cancers will lead to increased adoption of kyphoplasty devices, expected to drive the segment's growth.
North America accounted for approximately 42.3% of the global vertebroplasty and kyphoplasty market share
North America region is expected to hold the largest market share over the forecast period owing to factors such as better healthcare infrastructure, rising funding from the government, awareness among people and healthcare industry stakeholders about available technologies, and the high concentration of market players in the region.
For instance, in September 2022, RevBio was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health. With the help of this grant, the company will be able to develop Tetranite, a patented bone adhesive technology, for the treatment of vertebral compression fractures.
Therefore, such funding for the development of technologies in vertebral compression fractures is expected to drive market growth due to the increased launch and adoption of products in the market over the forecast period.
Furthermore, according to Osteoporosis Canada, 2022, more than 2.3 million Canadians are living with osteoporosis and at least 1 in 3 women and 1 in 5 men suffer from an osteoporotic fracture during their lifetime. Such a huge prevalence of osteoporosis in Canada is expected to increase the adoption of vertebroplasty and kyphoplasty procedures in the Canadian population, thereby leading to the rising adoption of vertebroplasty and kyphoplasty devices, driving the market growth.
The COVID-19 pandemic significantly impacted the global vertebroplasty and kyphoplasty market. Hospital admissions for patients other than COVID-19 and serious diseases were restricted to hospitals to avoid the spread of the virus.
For instance, according to the study published in SAGE Journals in April 2022, there have been noticeable changes in the hospital admissions of patients with vertebral compression fractures (VCF) compared to the period before the COVID-19 pandemic. Fewer patients visited the emergency department for VCF during the peak of the Covid-19 pandemic which represented a 44% decrease. Hence, COVID-19 affected the pace of the market at the beginning of the pandemic.
The major global players in the vertebroplasty and kyphoplasty market include Medtronic, Jayon Implants, Johnson & Johnson, Joimax, Teknimed, Globus Medical, Stryker, MEDAID Inc, Biopsybell, and Merit Medical Systems among others.
The global vertebroplasty and kyphoplasty market report would provide approximately 62 tables, 55 figures, and 182 Pages.
Target Audience 2024
LIST NOT EXHAUSTIVE